N/A
N=124
Cognitive Behavioral Treatments for Post-traumatic Stress Disorder (PTSD) Sleep Disturbance
Post-traumatic Stress Disorder
Bottom Line
View on ClinicalTrials.gov: NCT00108628 ↗Enrolled (actual)
124
Serious AEs
0.0%
Results posted
Feb 2015
Primary outcome: Primary: Weekly Number of Nightmares — 3.95; 3.88; 3.28; 3.47 weekly nightmares
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Imagery Rehearsal (Behavioral); Sleep and Nightmare Management (Behavioral)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- US Department of Veterans Affairs
- Primary completion
- Sep 2008
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Weekly Number of Nightmares |
3.95; 3.88; 3.28; 3.47; 3.61; 3.09 | — |
| PRIMARY Weekly Nights With a Nightmare |
2.96; 3.00; 2.67; 2.78; 3.10; 2.55 | — |
| PRIMARY Pittsburgh Sleep Quality Index |
13.40; 12.85; 12.09; 11.82; 12.57; 11.70 | — |
| SECONDARY Pittsburgh Sleep Quality Index - Addendum |
17.51; 17.01; 16.71; 16.29; 16.58; 16.36 | — |
| SECONDARY Nightmare Effects Survey |
26.39; 24.11; 24.12; 24.66; 25.28; 24.02 | — |
| SECONDARY PTSD Military Checklist |
62.73; 65.06; 58.83; 60.96; 60.13; 61.13 | — |
| SECONDARY Beck Depression Inventory |
26.85; 23.51; 24.16; 22.31; 24.80; 23.76 | — |
| SECONDARY SF-36 Physical Component |
37.17; 38.53; 39.48; 36.84; 37.72; 35.96 | — |
| SECONDARY SF-36 Mental Component |
29.69; 34.52; 32.33; 32.84; 30.98; 34.00 | — |
| SECONDARY Clinician-Administered PTSD Scale (CAPS) |
81.34; 79.48; 74.04; 74.85 | — |
Summary
The purpose of this study is to compare the effectiveness of two cognitive behavioral group psychotherapy interventions in controlling the subjective sleep disturbance in veterans with Post-traumatic Stress Disorder.
Eligibility Criteria
Inclusion Criteria
- Male
- Vietnam Combat Veteran
- Diagnosis of combat-related PTSD
- Stable psychotropic regimen for a minimum of three months
- Experiences recurrent nightmares
Exclusion Criteria
- Bipolar disorder, delirium, dementia, amnestic and other cognitive disorders
- Schizophrenia and other psychotic disorders
- Substance abuse or dependence within the last six months
- Untreated medical disorders known to impact sleep
Data sourced from ClinicalTrials.gov (NCT00108628). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.